Category III Codes
J5 · Effective Oct 1, 2015
69 active Medicare policies list E08.49, and 9 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J15 · Effective Nov 2, 2020
J9 · Effective Oct 11, 2020
J6 · Effective Dec 1, 2020
JK · Effective Dec 1, 2020
JE · Effective Nov 2, 2020
JF · Effective Nov 2, 2020
JH · Effective Oct 11, 2020
9 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of E08.49 |
|---|---|---|
| Diabetic Neuropathy: Selected Treatments | Feb 20, 2024 | Covered |
| Nerve Fiber Density Measurement | Oct 11, 2023 | Covered |
| Pulsed Electromagnetic Stimulation | Mar 14, 2023 | Covered |
| Pulsed Radiofrequency | Sep 20, 2023 | Covered |
| Vitamin B-12 Therapy | Feb 19, 2024 | Covered |
JL · Effective Oct 11, 2020
JJ · Effective Apr 18, 2021
JM · Effective Apr 18, 2021
J5 · Effective Oct 11, 2020
J8 · Effective Oct 11, 2020
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JE · Effective Jun 1, 2016
JF · Effective Jun 1, 2016
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Jan 29, 2018
JM · Effective Jan 29, 2018
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JE · Effective Mar 13, 2017
JF · Effective Mar 13, 2017
National · Effective Jan 1, 2026
J5 · Effective Oct 1, 2025
JL · Effective Sep 10, 2026
J6 · Effective Sep 10, 2026
National · Effective Oct 1, 2026
National · Effective Sep 10, 2026
J9 · Effective Sep 10, 2026
J5 · Effective Sep 10, 2026
National · Effective Sep 10, 2026
National · Effective Oct 1, 2026
National · Effective May 7, 2026
JL · Effective Oct 1, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J9 · Effective Oct 1, 2025
National · Effective May 7, 2026
J5 · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
J6 · Effective Apr 1, 2026
National · Effective Jun 4, 2026
JL · Effective Oct 1, 2025
National · Effective Nov 1, 2025
National · Effective Nov 6, 2025
National · Effective Aug 6, 2026
J6 · Effective Apr 1, 2026
National · Effective Oct 1, 2026
National · Effective Jan 25, 2026
National · Effective Feb 18, 2025
National · Effective Dec 5, 2024
| Policy |
|---|
| Effective |
|---|
| Status of E08.49 |
|---|
| Laboratory Evaluation of Vitamin B12 | Jan 6, 2026 | Covered |
|---|---|---|
| Peripheral Nerve Blocks for Treatment of Neuropathic Pain | Apr 15, 2026 | Not covered |
| Skin Nerve Fiber Density Testing | Jan 6, 2026 | Covered |
| Policy | Effective | Status of E08.49 |
|---|---|---|
| Evoked Potential Testing | Not recorded | Covered |